- Home
- COLL vs UAN Comparison
COLL vs UAN Comparison
Compare COLL & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- UAN
- Stock Information
- Founded
- COLL 2002
- UAN 2007
- Country
- COLL United States
- UAN United States
- Employees
- COLL N/A
- UAN N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- UAN Agricultural Chemicals
- Sector
- COLL Health Care
- UAN Industrials
- Exchange
- COLL Nasdaq
- UAN Nasdaq
- Market Cap
- COLL 958.8M
- UAN 941.8M
- IPO Year
- COLL 2015
- UAN 2011
- Fundamental
- Price
- COLL $37.03
- UAN $89.34
- Analyst Decision
- COLL Strong Buy
- UAN
- Analyst Count
- COLL 4
- UAN 0
- Target Price
- COLL $44.25
- UAN N/A
- AVG Volume (30 Days)
- COLL 380.6K
- UAN 28.9K
- Earning Date
- COLL 08-07-2025
- UAN 07-30-2025
- Dividend Yield
- COLL N/A
- UAN 7.57%
- EPS Growth
- COLL N/A
- UAN 77.68
- EPS
- COLL 1.06
- UAN 8.32
- Revenue
- COLL $707,007,000.00
- UAN $576,184,000.00
- Revenue This Year
- COLL $20.47
- UAN N/A
- Revenue Next Year
- COLL $2.91
- UAN N/A
- P/E Ratio
- COLL $35.07
- UAN $10.73
- Revenue Growth
- COLL 22.61
- UAN 8.15
- 52 Week Low
- COLL $23.23
- UAN $62.94
- 52 Week High
- COLL $42.29
- UAN $98.99
- Technical
- Relative Strength Index (RSI)
- COLL 69.53
- UAN 44.48
- Support Level
- COLL $29.70
- UAN $95.00
- Resistance Level
- COLL $38.24
- UAN $98.99
- Average True Range (ATR)
- COLL 1.23
- UAN 2.60
- MACD
- COLL 0.71
- UAN -0.71
- Stochastic Oscillator
- COLL 87.29
- UAN 9.87
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.